IC
SNV

Innealta Capital’s Synovus SNV Stock Holding History

Innealta Capital’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,066
Closed -$42.8K – 1451
2024
Q2 		$42.8K Buy
+1,066
New +$40.4K 0.01% 404

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Innealta Capital's SNV Position: Q3 2024 in Review

Innealta Capital sold out of Synovus (SNV) in Q3 2024, closing a stake of 1,066 shares — an estimated $42.8K sold.

Innealta Capital first reported a position in SNV in Q2 2024 and held it in 1 quarter. The position peaked at $42.8K in Q2 2024. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Innealta Capital reported no remaining Synovus position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 1,066 Synovus shares in Q3 2024, an estimated $42.8K.
  • Innealta Capital first reported a position in Synovus in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Synovus position peaked at $42.8K in Q2 2024.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.